These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 4173080)

  • 1. Refractoriness of prostatism to hydroxyprogesterone capronate (delalutin) therapy.
    Weinberg SR
    J Urol; 1968 Jul; 100(1):57-8. PubMed ID: 4173080
    [No Abstract]   [Full Text] [Related]  

  • 2. [Results and considerations on several cases of prostatic hypertrophy treated with hydroxyprogesterone capronate].
    Tinunin O
    Minerva Urol; 1969; 21(4):107-20. PubMed ID: 4192306
    [No Abstract]   [Full Text] [Related]  

  • 3. Evaluation of hydroxyprogesterone caproate in the treatment of benign prostatic hyperplasia.
    Jacobs D; Harper JM; Politano VA
    South Med J; 1967 Nov; 60(11):1174-6. PubMed ID: 4168673
    [No Abstract]   [Full Text] [Related]  

  • 4. Estrogenic management of benign prostatism, including early and poor-risk cases. 7-year experience.
    Roberts HJ
    J Am Geriatr Soc; 1966 Jul; 14(7):657-701. PubMed ID: 4160996
    [No Abstract]   [Full Text] [Related]  

  • 5. [Phonophoresis of hydroxyprogesterone capronate in the treatment of the patients with adenoma of the prostate complicated by dysuria].
    Karpukhin VT; Sapozhnikov VV
    Vopr Kurortol Fizioter Lech Fiz Kult; 1981; (6):46-9. PubMed ID: 6175097
    [No Abstract]   [Full Text] [Related]  

  • 6. [On the treatment of prostatic adenoma with hydroxyprogesterone caronate].
    Ibba AL
    Osp Ital Chir; 1968; 19(4):427-42. PubMed ID: 4180617
    [No Abstract]   [Full Text] [Related]  

  • 7. [Treatment of benign prostatic hypertrophy with progestogens including gestonorone caproate].
    Nagel R; Hargenda B
    Hinyokika Kiyo; 1970 Sep; 16(9):423-8. PubMed ID: 4097356
    [No Abstract]   [Full Text] [Related]  

  • 8. Effect of 17-alpha-hydroxyprogesterone 17-n-caproate on urine flow.
    Brooks ME; Braf ZF
    Urology; 1981 May; 17(5):488-91. PubMed ID: 6165131
    [No Abstract]   [Full Text] [Related]  

  • 9. [Pathogenesis and norsteroid treatment of bladder neck adenoma (prostatic hypertrophy)].
    Magyarsóky F
    Acta Chir Acad Sci Hung; 1973 Aug; 14(3):209-22. PubMed ID: 4129777
    [No Abstract]   [Full Text] [Related]  

  • 10. [Animal experimental studies using 19-nor-17 alpha-hydroxyprogesterone caproate (Gestenoroncapronat) with respect to a possible therapeutic application in prostatic adenoma].
    Hahn JD; Neumann F; Berswordt-Wallrabe R
    Urologe; 1968; 7(4):208-14. PubMed ID: 4177764
    [No Abstract]   [Full Text] [Related]  

  • 11. [Hormonal treatment of prostatic hypertrophy with special reference to the usefulness of gestagens].
    Musierowicz A
    Wiad Lek; 1974 Nov; 27(22):1985-8. PubMed ID: 4140619
    [No Abstract]   [Full Text] [Related]  

  • 12. Effect of hydroxyprogesterone caproate on experimental benign prostatic obstruction in the mouse.
    Caine M; Superstine E
    Isr J Med Sci; 1973; 9(11):1559-64. PubMed ID: 4130461
    [No Abstract]   [Full Text] [Related]  

  • 13. [Conservative treatment of prostatic hypertrophy with gestagens].
    Baevskiĭ IuL
    Urol Nefrol (Mosk); 1974; 39(4):31-3. PubMed ID: 4137390
    [No Abstract]   [Full Text] [Related]  

  • 14. [Studies using synthetic progestogens in drug therapy of so-called prostatic hypertrophy].
    Scultéty S; Sas M; Varga B
    Z Urol Nephrol; 1973 Jan; 66(1):49-59. PubMed ID: 4121364
    [No Abstract]   [Full Text] [Related]  

  • 15. [Clinical and cysto-sphincterometric results of progestogen therapy of prostatic adenoma].
    Makrigiannis D; Gaca AH
    Clin Ter; 1971 Jun; 57(5):399-416. PubMed ID: 4107104
    [No Abstract]   [Full Text] [Related]  

  • 16. [Use of rectal hydroxyprogesterone capronate phonophoresis for correction of endocrine disorders in patients with prostatic adenoma].
    Grigor'eva VD; Sapozhnikov VV; Ponomarev IuT; Bobkova AS; Korobkina EG
    Vopr Kurortol Fizioter Lech Fiz Kult; 1984; (6):29-32. PubMed ID: 6084361
    [No Abstract]   [Full Text] [Related]  

  • 17. Therapy with progestational agents in advanced benign prostatic hypertrophy.
    Geller J; Angrist A; Nakao K; Newman H
    JAMA; 1969 Nov; 210(8):1421-7. PubMed ID: 4187537
    [No Abstract]   [Full Text] [Related]  

  • 18. [Anti-androgens. Animal experiments and clinical application].
    Neumann F; Steinbeck H
    Internist (Berl); 1971 May; 12(5):198-205. PubMed ID: 4103750
    [No Abstract]   [Full Text] [Related]  

  • 19. Medical treatment of benign nodular prostatic hyperplasia with cyproterone acetate.
    Scott WW; Wade JC
    J Urol; 1969 Jan; 101(1):81-5. PubMed ID: 4178189
    [No Abstract]   [Full Text] [Related]  

  • 20. [Clinico-morphological correlations in treatment of endometrial cancer with 17- -hydroxyprogesterone capronate].
    Bokhman IaV; Chepik OF
    Vopr Onkol; 1971 Dec; 17(12):32-8. PubMed ID: 5144161
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.